GPT Healthcare Limited
NSE: GPTHEALTHINE486R01017·Healthcare·www.ilshospitals.com ↗·Mcap ₹1,321 Cr·Listed 2024
₹161.27▼ ₹0.46  (−0.28%)
52W: ₹115 – ₹175 · Vol: 66.9K shares · Close 25 Sept
Set Alert

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q3 FY24
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24
Revenue from operations12612612011910710110210697.899.496.6
Other income21.61.41.31.61.61.92.82.21.61.2
Total expenses11111210910597.686.686.587.885.482.681.8
EBITDA24.223.420.722.717.420.721.323.41823.221
EBITDA margin19.2%18.5%17.2%19.1%16.2%20.4%20.8%22.2%18.4%23.3%21.7%
Finance costs2.22.22.32.21.610.90.70.91.61.7
Depreciation6.96.97.16.86.24.94.74.84.74.84.5
Profit before tax17.215.912.815.111.116.417.620.714.718.416
Tax4.41.33.44.53.43.55.45.94.75.64.5
Net profit12.714.69.410.67.712.912.214.81012.811.5
Net margin10.1%11.5%7.8%8.9%7.2%12.7%12.0%14.0%10.2%12.9%11.9%
EPS (₹)1.551.781.141.290.941.571.491.811.211.591.44
Net profit YoY+65.7%+13.0%−23.5%−28.5%−22.9%+0.6%+6.8%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24
Revenue from operations473407400
Other income68.55.3
Total expenses424346337
EBITDA84.283.487.8
EBITDA margin17.8%20.5%21.9%
Finance costs8.23.57.1
Depreciation27.11918
Profit before tax54.869.368
Tax12.619.420.3
Net profit42.249.947.8
Net margin8.9%12.3%11.9%
EPS (₹)5.156.085.96
Net profit YoY−15.4%+4.5%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24
Operating cash flow81.267.468.8
Investing cash flow−47.3−32.6−25.2
Financing cash flow−31.4−34.8−48.5
Capital expenditure41.849.919.4
Free cash flow (CFO − capex)39.317.549.4

Net profit trend

annual, ₹ crore
FY24
₹47.8
FY25
₹49.9+5%
FY26
₹42.2−15%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone3 Aug 2026PDF on NSE XBRL
Q4 FY26Standalone · audited18 May 2026PDF on NSE XBRL
Q3 FY26Standalone2 Feb 2026PDF on NSE XBRL
Q2 FY26Standalone8 Nov 2025PDF on NSE XBRL
Q1 FY26Standalone6 Aug 2025PDF on NSE XBRL
Q4 FY25Standalone · audited23 May 2025PDF on NSE XBRL
Q3 FY25Standalone11 Feb 2025PDF on NSE XBRL
Q2 FY25Standalone14 Nov 2024PDF on NSE XBRL
Q1 FY25Standalone13 Aug 2024PDF on NSE XBRL
Q4 FY24Standalone · audited21 May 2024PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 25.6×28.0×
P/B5Y avg 5.24×4.91×
ROEFY26, on average equity16.3%
Net margin8.9%
Debt / equity0.06×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹5.76
Market cap₹1,323 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
4.91×
vs 5-point avg 5.24× (−6%)
3.51× low5.24× avg6.62× high
History points are balance-sheet dates (2024 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹465 Cr+21%
Net worth₹269 Cr+9%
Total borrowings₹16 Cr+21%
Cash & bank balances₹4 Cr+149%
Investments₹43 Cr+34%
Inventories₹11 Cr+20%
Trade receivables₹20 Cr−19%
Trade payables₹42 Cr+21%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Feb 24
Promoter65.5765.5765.5765.5765.5765.5765.5765.5765.5765.5765.57
FII3.032.812.743.204.964.484.724.705.386.687.13
DII6.946.836.206.469.3211.3511.3011.9913.0812.8110.07
of which MF4.654.694.724.644.31––––––
Retail18.0118.3319.1118.9016.6515.5615.3315.0713.6012.1617.14
Other public6.456.466.385.873.503.043.082.672.372.780.09
62,454 shareholders · NSE shareholding pattern filings.